These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema. Saito W; Kase S; Ohgami K; Mori S; Ohno S Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334 [TBL] [Abstract][Full Text] [Related]
46. [Avastin a treatment of diabetic macular edema]. Stan C; Sevan S; Mureşan I Oftalmologia; 2011; 55(1):63-7. PubMed ID: 21774389 [TBL] [Abstract][Full Text] [Related]
47. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME; Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322 [TBL] [Abstract][Full Text] [Related]
48. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Arevalo JF; Sanchez JG; Wu L; Maia M; Alezzandrini AA; Brito M; Bonafonte S; Lujan S; Diaz-Llopis M; Restrepo N; Rodríguez FJ; Udaondo-Mirete P; Ophthalmology; 2009 Aug; 116(8):1488-97, 1497.e1. PubMed ID: 19545900 [TBL] [Abstract][Full Text] [Related]
49. OCT and cataract. Falavarjani KG; Modarres M; Nikeghbali A Ophthalmology; 2010 Apr; 117(4):849; author reply 849-50. PubMed ID: 20346827 [No Abstract] [Full Text] [Related]
50. [Treatment of diabetic macular oedema with the VEGF inhibitors ranibizumab and bevacizumab: conclusions from basic in vitro studies]. Lang GE; Lang GK; Deissler HL Klin Monbl Augenheilkd; 2014 May; 231(5):527-34. PubMed ID: 24799173 [TBL] [Abstract][Full Text] [Related]
51. Bevacizumab local complications. Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862 [No Abstract] [Full Text] [Related]
53. Intravitreal foreign body following intravitreal anti-VEGF injection: a case report. Al Bdour MD; Ali ZR Eye (Lond); 2014 Feb; 28(2):244-5. PubMed ID: 24357842 [No Abstract] [Full Text] [Related]
54. Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Salam A; Mathew R; Sivaprasad S Acta Ophthalmol; 2011 Aug; 89(5):405-11. PubMed ID: 21294854 [TBL] [Abstract][Full Text] [Related]